Shareholders deserve some answers

I am struggling to find ANY results to numerous claims by the Company in their announcements regarding Natshield.

Large orders received, strong demand, increased numbers.

But where are the Dollars ?

ASX Announcement
10 February 2020

HOLISTA INCREASES SHIPMENTS FOR NATSHIELD™ SANITISERS FROM 60,000 TO 150,000,
PLANS BOTTLING IN AUSTRALIA TO MEET AUSTRALIAN AND NEW ZEALAND DEMAND.

KUALA LUMPUR/PERTH, 10 FEBRUARY 2020 – Holista CollTech (ASX:HCT, “Holista”)
announced today that it will ship a further 90,000 NatShield™ sanitisers after receiving fresh
orders from Malaysia, Australia and other parts of Asia, just days after the first 60,000 units
were sold out amidst rising concerns of the spread of the deadly coronavirus that originated
from Wuhan, China.

NatShield™ sanitisers contains Path-Away®. Path-Away® is a plant-based active ingredient
proven to kill over 170 pathogens and previously known corona-type viruses and developed
by Global Infections Control Consultants LLC (GICC) of South Carolina, U.S.A.. Path-Away® is
approved for use by Malaysia's Ministry of Health, with special reference to the H1N1 virus.
Until now, Holista has been shipping in the active ingredient in drums before it is combined
with purified water under strict supervision and bottled in Malaysia.
Each 20-ml bottle contains 3% of Path-Away® which attacks the cell walls of the microbes,
inhibiting their uptake of amino acids – the basic building block of cells – needed for
reproduction. The microbes then clump together and kill themselves in the process. Free of
alcohol and other potentially toxic chemicals, it is not harmful to humans and pets even if
accidentally swallowed.

Holista said that it received orders last week for 60,000 units from Australia (30,000 bottles)
and a Southeast Asian distributor (30,000). Together, the total confirmed orders as at
February 8 amount to 107,000, far exceeding the first shipment of 60,000 units.
The orders for Australia have come from a pharmacy group in Sydney and another in
Melbourne and are intended for retail in Australia and New Zealand. Due to shortages of
bottles faced by Malaysian bottlers, Holista has commenced advanced negotiations with
bottlers in Australia.

“We will announce details of the bottling arrangement and local
production in Australia when details are finalised. Once finalised, Australia can then supply
not only here but into New Zealand and even Asia ” said Director Daniel O'Connor.
Path-Away® is approved by the Food and Safety Authority and Environmental Protection
Authority of New Zealand. It has been successfully tested in several World Health
Organization approved laboratories.


Holista is its exclusive distributor in the ASEAN region of Path-Away®. The ingredients used to
produce Path-Away® are certified as Generally Regarded As Safe (GRAS) and approved by the
U.S. Food and Drug Administration (FDA) and exempted by the U.S. Environmental Protection
Agency (EPA). It is listed in the United States Pharmacopeia (USP) and has undergone
successful USP-51 testing as a disinfectant.
Holista intends develop a nasal balm version of the sanitser, featuring Path-Away®. It has
accelerated development of this product and intends to file a global patent by March 2020,
and make the product available to the market by July 2020.
This announcement has been approved for release by all members of the Holista Board
#END OF PRESS RELEASE#



ASX Announcement
6 February 2020

DEVELOPMENT OF NATSHIELD™ NASAL BALM WITH PATH-AWAY® AS BARRIER TO VIRUSES

KUALA LUMPUR/PERTH, 6 FEBRUARY 2020 – ASX-listed Holista CollTech Limited (ASX:HCT,
Holista) is pleased to announce the accelerated development of its nasal balm version of the
NatShield™ Sanitiser, featuring Path-Away® as the principle active ingredient. The nasal balm is
an all-natural sanitizer to reduce the risk of viral infection via the nose, either through inhaled or
via touch (hand to nose).
The global patent will be filed by the end of March 2020, with plans to make available to the
market product by the end of July 2020.

Natshield™ Sanitizer Sales Update

Holista announced on 29 January 2020 the increase demand for NatShield™ Sanitizer. Holista
wishes to inform that the entire shipment of 60,000 bottles that was ordered to fulfil the demand
is completely sold. New inquiries and orders are received daily from Malaysia and Singapore, and
Holista has placed a significantly larger shipment order to meet the increasing demand. Fresh
enquiries for orders have arrived from Australia, Thailand, Philippines and Cambodia
ENDS

ASX Announcement
20 February 2020

HOLISTA PARTNERS GLOBAL INFECTIOUS CONTROL CONSULTANTS LLC, THE U.S. DEVELOPER
OF PATH-AWAY®, TO CO-DEVELOP NASAL SANITISING BALM FOR GLOBAL MARKETS.

HOLISTA EXTENDS DISTRIBUTION OF PATH-AWAY® BASED NATSHIELD™ SANITISER TO
INCLUDE ASEAN, UK AND EUROPE.

UPDATE ON HAND-HELD SANITISER; COLLABORATING WITH BOTTLERS IN THE PHILIPPINES

The hand-held NatShield™ Sanitiser, containing Path-Away® and developed by Holista is
currently bottled in Malaysia and distributed within the 10-country ASEAN region. Stocks have
run out in local pharmacies and Holista said today it working with three bottlers in the Philippines
to meet orders.
Dr Rajen Manicka, CEO of Holista CollTech, said, “Due to health concerns about COVID-19, Holista
is striving to meet the demands for the hand-held NatShield™ Sanitiser locally in Malaysia as well
as in Australia”.

DISTRIBUTION EXTENDED BEYOND ASEAN TO INCLUDE THE UK, EUROPE, AND NORTH
AMERICA

GICC LLC has agreed to grant Holista marketing and distribution rights of Path-Away® beyond
ASEAN region to include UK and Europe. Holista will distribute NatShield™ Sanitiser and the nasal
sanitising balm into the UK and Europe. Holista will also work collaboratively with GICC LLC in the
North American market to market NatShield™ Sanitiser and the nasal sanitiser balm.
“We are also grateful to Dr Martin and GICC LCC for granting Holista the distribution rights for
Path-Away® to include the UK and Europe. We are excited to collaborate Dr Martin’s team in the
North American market on the NatShield™ Sanitiser,” he added.

EQUIPMENT TO CLEANSE AIRFLOW IN BUILDINGS & FACILITIES

Under the leadership of Dr Martin, a trained engineer, GICC LCC has also developed a set of
equipment and processes that helps deploy Path-Away® in buildings such as airports,
transportation hubs, hospitals, schools and factories to improve the quality airflow. The solution
involves pumping mists containing Path-Away® into the air condition and ventilation systems to
destroy the deadly pathogens present in such enclosed public spaces.
It has been used for over a decade in various countries and market segments to prevent illness
and to increase productivity.

ASX Announcement
3 March 2020

UPDATE ON NATSHIELD™ SANITISER. HOLISTA and GICC LLC SIGN LETTER OF
CONFIRMATION TOWARD GLOBAL DISTRIBUTION RIGHTS

KUALA LUMPUR/PERTH, 2 MARCH 2020 – Holista CollTech (ASX:HCT, “Holista”) refers to the
announcements made to ASX since 29 January 2020 in relation to the NatShield™ hand-held
sanitiser which uses the active ingredient, Path-Away®. Holista has distribution rights in
various countries for the plant-based active ingredient developed by Global Infections Control
Consultants LLC (“GICC LLC”), which is headquartered in Bluffton, South Carolina in the United
States.

Confirmation toward Global rights for Path-Away®

The Company is pleased to announce that GICC LCC and Holista have exchanged a Letter of
Confirmation that, subject to a final agreement being signed, grants Holista distribution
rights for NatShield™ sanitiser (and later, the nasal sanitiser balm) globally. The global
distribution rights commenced on 2 March 2020.

Orders of NatShield™ as at 29 February 2020

Holista bottles, markets and distributes the 20-ml handheld NatShield™ sanitiser containing
3% Path-Away®. The active ingredient is currently shipped to Malaysia where the sanitiser is
diluted as per the protocols of GICC LLC and bottled. Until January 2020, the primary market
was Malaysia for which Holista has distribution agreements with 7 major pharmacy chains
and a network of 2,700 pharmacies and health shops.

As at 29 February 2020 the Company had received orders amounting to 210,000 bottles of
NatShield™, comprising of 20-ml, 30-ml and 60-ml sizes. This is an increase in orders from the
107,000 units announced on 8 February 2020.
The majority of the additional orders since 8 Febuary 2020 have come from outside of
Malaysia.
Based on the total orders as at 29 February 2020, the sales value of sanitisers amounts to
approximately AUD $1.4 Million.

Due to concerns about the continuing spread of the Covid-19 coronavirus, the Company has
received expressions of interest from potential distributors or other buyers in:
- United States
- Canada, Europe
- United Kingdom
- Australia
- India
- Hong Kong
- Middle East

Update on bottling capacity

Of the orders received since the start of the year, Holista has already shipped a total of 21,260
20-ml units. These 21,260 units were bottled in Malaysia and sold mostly to Malaysians via
pharmacy chains.
Due to the increased demand for the sanitisers, Holista has added bottling capacity in recent
weeks. From an original two bottlers in Malaysia the Company has added bottling
arrangements with two more Malaysian bottlers and three more in The Philippines, bringing
the total to seven. All the bottlers – existing and newly appointed – have the required
certifications to bottle NatShield™. With these new bottling arrangements:
i) The Company can now produce NatShield™ sanitisers in the following sizes: 20-ml,
30-ml and 60-ml;
ii) The total new bottling capacity has increased to 50,000 per week or about 200,000
per month; and
iii) For the orders received up to 29 February 2020, the Company expects to complete
shipments by the end of March 2020.
This announcement has been approved for release by all members of the Holista Board.
On behalf of the Board
Dr Rajen M

ASX Announcement
19 March 2020

HOLISTA APPOINTS EXCLUSIVE U.S. DISTRIBUTOR FOR NATSHIELD ™ SANITISER WITH CONFIRMED SALES ORDER OF AUD #3.0 MILLION IN FIRST YEAR.

Holista CollTech (ASX:HCT, “Holista”) announced today that it has appointed Health Therapies LLC
(“Health Therapies”) as its Exclusive Distributor for the United States for the NatShield™
sanitiser amidst a sharp increase of Covid-19 coronavirus infection in the country. Health
Therapies LLC has exclusivity for the U.S. market for 3 years and has committed to a minimum
order of at least AUD$3.0 million per year.

The orders are for NatShield™ handheld sanitisers containing Path-Away®, a plant-based
active ingredient. Developed by South Carolina based Global Infection Control Consultants
LLC (“GICC LLC”), Path-Away® is proven effective for a broad spectrum of pathogens. Holista
has a global collaboration with GICC LLL and sells NatShield™ as a sanitiser which contains 3%
Path-Away®.